Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selegiline for functional recovery after stroke
IRCT20200719048136N1Phase 3Completed
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of selegiline in stroke (2 arms), sponsored by Shahrekord University of Medical Sciences. Primary endpoints: Cognitive function and Motor function. Started Aug 2020; status: completed.
02
Drugs
selegiline
03
Conditions
stroke
Beyond the preview
Go deeper on IRCT20200719048136N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200719048136N1.